Can a new sleep aid keep ICU patients from becoming delirious?
NCT ID NCT07407400
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a sleep medication called lemborexant can help older adults in the intensive care unit (ICU) sleep better and reduce their risk of delirium, a state of sudden confusion. The trial will involve 100 patients aged 65 and older who are in the surgical ICU. Participants will receive either lemborexant or a placebo for three nights, and researchers will measure sleep quality and delirium rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gentle massage at bedtime help kids with ADHD sleep?
- Do weighted blankets unlock better sleep for kids with ADHD?
- Gentle massage and calming sounds: a new bedtime ritual for autistic kids?
- Can a smart digital program restore sleep for cancer survivors?
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk